高樂股份(002348.SZ)擬向新鴻輝實業轉讓異度信息53.25%股權
格隆匯12月14日丨高樂股份(002348.SZ)公佈,公司於2020年12月13日召開第六屆董事會第十六次臨時會議,審議通過了《關於轉讓控股子公司股權的議案》,為加快公司資金回籠,改善公司財務水平,減輕公司經營負擔;優化公司資源配置,盤活存量資產,滿足公司未來資金需求,公司擬將持有的異度信息53.25%的股權進行轉讓,交易受讓方為普寧市新鴻輝實業投資有限公司(以下簡稱“新鴻輝實業”),成交價格為1.67億元,本次交易溢價59%。本次交易目的在於加快資金回籠,改善公司財務水平,減輕公司經營負擔;優化公司資源配置,盤活存量資產,滿足未來資金需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.